Best Practices in Electronic Data Capture for Clinical TrialsTips to Cut Costs and Increase Efficiency
$397.00
Product Details
Held July 12, 2007Whether your company currently uses EDC, or will transition to it soon, this must-attend audioconference helps you ensure success.
Drugmakers that use electronic data capture (EDC) for clinical trials will have a competitive advantage, bringing new drugs and therapies to market more productively and quickly. Leading drugmakers, including Wyeth and Amgen, plan to complete as much as 100% conversion to EDC by next year. Wyeth expects a $5 million reduction in data management costs by the end of 2006.
Selecting the most appropriate EDC solution for your company is a strategic business decision — not just an IT application decision. It requires commitment at every level of the clinical trials process. Make sure you do it right. In this 90-minute audio CD/Transcript, Paul Bleicher, M.D., Ph.D., of Phase Forward, a company that has experience with more than 1,000 clinical trials, hands you practical strategies for each stage of the EDC decision and implementation process.You will discover:
- How an EDC solution can enable early access to clinical data for drug safety assessment and risk identification
- How to use operational data from EDC systems to better manage the process of clinical trials
- What role standards play in EDC solutions
- How future EDC solutions would allow interoperability with other systems to strengthen clinical research
- How EDC solutions can enable adaptive designs for clinical trials
- EDC's potential role in electronic health records